Chime Bio’s bivalent shigella conjugate vaccine will commence Phase III clinical trials in Bangladesh.

Recently, Zhifei Biological’s wholly-owned subsidiary, Beijing Zhifei Green Bamboo, has completed preparations for Phase III clinical…